Document:

exv10w41

 

AMENDED AND RESTATED

PEROT SYSTEMS CORPORATION

2006 NON-EMPLOYEE DIRECTOR EQUITY COMPENSATION PLAN

ARTICLE ONE

GENERAL PROVISIONS

          I.      PURPOSE OF THE PLAN

          This Plan is intended to promote the interests of Perot Systems Corporation, a Delaware
corporation, by creating an equity incentive arrangement to attract and retain the services of
highly qualified non-employee Board members.

          Capitalized terms not otherwise defined herein shall have the meanings assigned to such terms
in the attached Appendix.

          II.      ADMINISTRATION OF THE PLAN

          Administration of the Plan shall be self-executing in accordance with its terms and no plan
administrator shall exercise any discretionary functions with respect to any stock issuance made
under the Plan except as provided in IV(B) below.

          III.      ELIGIBILITY

          Eligible Directors shall be limited to non-employee Board members (other than Ross Perot).

          IV.      STOCK SUBJECT TO THE PLAN

          A.      The stock issuable under the Plan shall be shares of authorized but unissued or reacquired
Common Stock, including shares repurchased by the Corporation on the open market. Subject to any
additional shares authorized by the vote of the Board and approved by the shareholders, the number
of shares of Common Stock reserved for issuance over the term of the Plan shall not exceed 500,000
shares.

          B.      If any change is made to the Common Stock by reason of any stock split, stock dividend,
recapitalization, combination of shares, exchange of shares or other change affecting the
outstanding Common Stock as a class without the Corporation’s receipt of consideration, appropriate
adjustments shall be made by the Plan Administrator to the maximum number and/or class of
securities issuable under the Plan. Such adjustments are to be effected in a manner that shall
preclude the enlargement or dilution of rights and benefits hereunder. The adjustments determined
by the Plan Administrator shall be final, binding and conclusive.

 

 

ARTICLE TWO

DIRECTOR AUTOMATIC GRANTS

          I.      TERMS

          A.      Grant Dates. Grants under this Article Two shall be made on the dates specified
below:

                    1.      Each individual who is first elected or appointed as a non-employee Board member at any
time on or after May 31, 2006 shall automatically be granted, on the date of such initial election
or appointment, a number of shares equal to the product of (a) the number of months (including full
and partial months) remaining until the next June 1 divided by 12 and (b) 5,000, provided that
individual has not previously been in the employ of the Corporation or any Parent or Subsidiary
within the three year period ending on the date of such initial election or appointment.

                    2.      On June 1 of each year, beginning with 2006, each individual who is to continue to serve as
an Eligible Director, whether or not that individual is standing for re-election to the Board at
that particular annual meeting of shareholders, shall automatically be granted an additional 5,000
unrestricted shares of Common Stock. There shall be no limit on the number of such stock awards
any one Eligible Director may receive over his or her period of Board service, and non-employee
Board members who have previously been in the employ of the Corporation (or any Parent or
Subsidiary) shall be eligible to receive one or more such annual stock awards over their period of
continued Board service.

          B.      Issuance of Shares. Each stock award for 5,000 shares shall be immediately vested
and shall be issued to the applicable Eligible Director as soon as administratively practicable
after such Eligible Director becomes entitled to the award.

          C.      Deferral Election. Each Eligible Director may elect to defer receipt of a future
year’s stock award to the date his or her service terminates, in accordance with the rules of this
Section. An election to defer must apply to the entire stock award for the year in question and
must be made prior to the start of the calendar year in which the award is to be made. A deferral
election once made shall continue in effect for each subsequent year’s award unless revoked not
later than the last day of the calendar year immediately preceding the calendar year in which the
next annual award is to be made. A deferral election for any particular year’s award shall become
irrevocable as of the last day of the immediately preceding calendar year. All deferred stock
awards shall be issued in a lump sum stock issuance on the 30th day following the date of the
Eligible Director’s cessation of service or as soon after that scheduled payment date as is
administratively practicable, but in no event later than the 15th day of the 3rd calendar month
following such cessation of service.

 

 

ARTICLE THREE

MISCELLANEOUS

          I.      TAX WITHHOLDING

          The Corporation’s obligation to deliver shares of Common Stock shall be subject to the
satisfaction of all applicable federal, state and local income and employment tax withholding
requirements. Effective September 28, 2006, Eligible Directors to whom awards are made under the
Plan (other than the awards made under the automatic grant program) may use shares of Common Stock
in satisfaction of all or part of the withholding taxes to which such individuals may become
subject in connection with the issuance, exercise or vesting of those awards. At the Participant’s
election, the Corporation shall withhold, from the shares of Common Stock otherwise issuable, a
portion of those shares with an aggregate fair market value equal to the percentage of the
withholding taxes (not to exceed one hundred percent (100%)) designated by such individual. The
shares of Common Stock so withheld shall reduce the number of shares of Common Stock authorized for
issuance under the Plan. Withholding taxes shall mean the applicable income and employment
withholding taxes which the Corporation must collect from the Participant in connection with the
issuance, exercise or vesting of the award made to him or her under the Plan.

          II.      EFFECTIVE DATE AND TERM OF THE PLAN

          A.      The Plan became effective immediately on the Plan Effective Date. Awards may be granted
under the Plan at any time on or after the Plan Effective Date.

          B.      The Plan shall terminate upon the earliest to occur of (i) May 31, 2016 or (ii) the date on
which all shares available for issuance under the Plan shall have been issued as fully-vested
shares.

          III.      AMENDMENT OF THE PLAN

          The Board shall have complete and exclusive power and authority to amend or modify the Plan in
any or all respects. In addition, shareholder approval will be required for any amendment to the
Plan that (i) materially increases the number of shares of Common Stock available for issuance
under the Plan, (ii) materially expands the class of individuals eligible to receive awards under
the Plan, (iii) materially increases the benefits accruing to the Participants under the Plan (iv)
materially extends the term of the Plan, (v) expands the types of awards available for issuance
under the Plan, or (vi) is otherwise required by applicable laws, rules or regulations, including
but not limited to any rules of any stock exchange or market system on which the Common Stock is
then listed for trading.

          IV.      REGULATORY APPROVALS

          A.      The implementation of the Plan, the issuance of any shares of Common Stock pursuant to any
award under the Plan shall be subject to the Corporation’s procurement of all

 

 

approvals and permits required by regulatory authorities having jurisdiction over the Plan,
the stock granted under it and the shares of Common Stock issued pursuant to it.

          B.      No shares of Common Stock or other assets shall be issued or delivered under the Plan
unless and until there shall have been compliance with all applicable requirements of Federal and
state securities laws, including the filing and effectiveness of the Form S-8 registration
statement for the shares of Common Stock issuable under the Plan, and all applicable listing
requirements of any stock exchange or market system on which Common Stock is then listed for
trading.

          V.      NO EMPLOYMENT/SERVICE RIGHTS

          Nothing in the Plan shall confer upon the Participant any right to continue in Service for any
period of specific duration or interfere with or otherwise restrict in any way the rights of the
Corporation (or any Parent or Subsidiary employing or retaining such person) or of the Participant,
which rights are hereby expressly reserved by each, to terminate such person’s Service at any time
for any reason, with or without cause.

          VI.      COMPLIANCE WITH 409A

          The Plan and all awards granted hereunder are intended to comply with the requirements of Code
Section 409A and shall be administered accordingly, including, without limitation, the delay in
payment of all deferred awards for six months after the Participant’s termination of service for
any Participant who is a “specified employee” within the meaning of Code Section 409A.

 

 

APPENDIX

          The following definitions shall be in effect under the Plan:

                    A.      Board shall mean the Corporation’s Board of Directors.

                    B.      Code shall mean the Internal Revenue Code of 1986, as amended.

                    C.      Common Stock shall mean the Corporation’s Class A Common Stock.

                    D.      Corporation shall mean Perot Systems Corporation, a Delaware corporation, and any
corporate successor to all or substantially all of the assets or voting stock of Perot Systems
Corporation, which shall by appropriate action adopt the Plan.

                    E.      Eligible Director shall mean a non-employee Board member eligible to participate in
this Plan in accordance with the eligibility provisions of Articles One and Three.

                    F.      Parent shall mean any corporation (other than the Corporation) in an unbroken chain
of corporations ending with the Corporation, provided each corporation in the unbroken chain (other
than the Corporation) owns, at the time of the determination, stock possessing 50% or more of the
total combined voting power of all classes of stock in one of the other corporations in such chain.

                    G.      Participant shall mean any person who is issued shares of Common Stock under the
Plan.

                    H.      Plan shall mean the Corporation’s 2006 Non-Employee Director Equity Compensation
Plan, as set forth in this document.

                    I.        Plan Administrator shall mean the Corporation.

                    J.       Plan Effective Date shall mean May 31, 2006, except as expressly provided otherwise
in this Plan document.

                    K.      Service shall mean the performance of services for the Corporation (or any Parent
or Subsidiary) by a person in the capacity of an employee, a non-employee member of the board of
directors or a consultant or independent advisor, except to the extent otherwise specifically
provided in the documents evidencing the stock award thereunder. For purposes of the Plan, a
Participant shall be deemed to cease Service immediately upon the date on which the Participant no
longer performs services in any of the foregoing capacities for the Corporation or any Parent or
Subsidiary.

                    L.      Subsidiary shall mean any corporation (other than the Corporation) in an unbroken
chain of corporations beginning with the Corporation, provided each corporation (other than the
last corporation) in the unbroken chain owns, at the time of the determination, stock possessing
50% or more of the total combined voting power of all classes of stock in one of the other
corporations in such chain.exv10w1

 

Exhibit 10.1

CONSULTING AGREEMENT

This consulting agreement (this “Agreement”) is made effective for all purposes and in all respects
as of September 29, 2006 the date of the last signature hereto (the “Effective Date”), by and
between Boston Life Sciences, Inc., a Delaware corporation with its principal offices located at 85
Main Street, Hopkinton, MA 01748 (hereinafter referred to as “BLSI”), and Robert S. Langer, Jr.,
Sc.D. (hereinafter referred to as “Consultant”).

WHEREAS, BLSI desires to engage Consultant to perform certain duties as shall be assigned to
Consultant by BLSI from time to time;

WHEREAS, Consultant desires to be so engaged by BLSI; and

WHEREAS, BLSI and Consultant desire to set forth in writing the terms and conditions of their
agreements and understandings.

NOW, THEREFORE, in consideration of the foregoing, of the mutual promises herein contained, and of
other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto, intending legally to be bound, hereby agree as follows:

	1.	 	Duties of Consultant. Consultant shall perform such duties as shall be assigned to
Consultant by BLSI, including, but not limited to providing scientific and business consulting
services. Consultant further agrees to be available at mutually agreeable times during the
term of this Agreement. Consultant agrees to perform this work in a prompt, efficient and
professional manner.
	 
	2.	 	Term of Engagement. The term of Consultant’s engagement hereunder (the “Term”) shall
commence as of the Effective Date and shall continue until either BLSI or Consultant shall
terminate such engagement without cause upon not less than twenty days prior written notice to
the other party. BLSI may immediately terminate this Agreement at any time upon written
notice to Consultant in the event of a breach of this Agreement by Consultant which cannot be
cured (e.g., a breach of Section 5) or in the event that Consultant is accused of a felony or
materially unethical conduct. In addition, BLSI may terminate this Agreement for cause at any
time upon ten (10) days prior written notice to Consultant. Cause shall mean (i) a material
breach by Consultant of this Agreement where such breach can be cured and is not remedied
within such ten (10) day period, (ii) the physical or mental inability of Consultant to
perform the consulting services contemplated under this Agreement or (iii) the unsatisfactory
performance of the consulting services contemplated under this Agreement which unsatisfactory
performance is not remedied within such ten (10) day period. Notwithstanding the

 

 

	 	 	foregoing,
Consultant’s covenants and obligations set forth in Sections 5, 6, 7 and Section 11 hereof
shall survive the termination of this Agreement for any reason.
	 
	3.	 	Compensation. Subject to compliance by Consultant with this Agreement, BLSI shall pay
Consultant $13,125 per calendar quarter, in arrears (pro-rated on a per diem basis in the case
of any partial quarters during the Term). During the Term, BLSI shall not be obligated, under
any circumstances, to pay for, or keep in effect, any hospitalization, health or life
insurance for the benefit of Consultant, to pay any employment or similar taxes, to make any
tax withholdings or to provide any benefits that BLSI provides to its employees.
	 
	4.	 	Expenses Incurred. During the Term, BLSI shall reimburse Consultant for all
reasonable travel and other business expenses paid or incurred by Consultant in connection
with the performance of Consultant duties hereunder, upon presentation of expense statements,
vouchers or other evidence of expenses providing the detail required by BLSI.
	 
	5.	 	Treatment of Information. 

	 	A.	 	Consultant acknowledges that he shall or may be making use of, viewing and adding to
confidential information of a special and unique nature and value relating to such matters as
BLSI’s trade secrets, systems, designs, methods, computer software programs, documentation,
manuals, white papers, other confidential reports and communications and lists of and
information relating to suppliers, customers and prospects (“Confidential Information”).
Consultant further acknowledges that any information and materials received by BLSI from third
parties in confidence shall be included in the definition of Confidential Information.
Consultant agrees that he shall not directly or indirectly disclose, divulge, reveal, report,
publish, transfer or use, for any purpose whatsoever, any Confidential Information to any
third party without the express authorization by BLSI. Consultant agrees not to make any
copies of the Confidential Information (except when appropriate for the furtherance of this
Agreement or duly and specifically authorized to do so). As any breach by Consultant of his
covenants and agreements in this section may cause irreparable injury to BLSI that cannot be
redressed by the payment of monies, BLSI shall be entitled to enjoin any such threatened or
continuing violation. Consultant acknowledges that BLSI holds all right, title, and interest
in and to all tangible and intangible incidents of the Confidential Information, including,
without limitation, all trade secrets, copyrights, patent rights and derivative works
pertaining thereto, and that this Agreement conveys to Consultant only a limited right to use
the Confidential Information in the course of performing this Agreement. Such right is fully
revocable in accordance with the provisions of this Agreement. Consultant further agrees that,
except for such right of use, he shall not assert any right, title, or interest in or to the
Confidential Information and shall hold all Confidential Information in strict confidence.
	 
	 	B.	 	Confidential Information shall not include information which is or becomes publicly available
without breach of (i) this Agreement, (ii) any other agreement or

 

 

	 	 	 	instrument to which BLSI is
a party or a beneficiary or (iii) any duty owed to BLSI by Consultant or any third party;
provided, however, that Consultant hereby acknowledges and agrees that if Consultant shall
seek to disclose, divulge, reveal, report, publish, transfer or use any Confidential
Information to any third party, Consultant shall bear the burden of proving that any such
information shall have become publicly available without any such breach. Disclosure of
Confidential Information shall not be prohibited if such disclosure is directly
pursuant to a valid and existing order of a court or other governmental body or agency;
provided, however, that (i) Consultant shall first have given prompt notice to BLSI of any such
possible or prospective order (or proceeding pursuant to which any such order may result) and
(ii) BLSI shall have been afforded a reasonable opportunity to prevent or limit any such
disclosure. Consultant agrees to return all Confidential Information, and all documentary,
machine-readable or other elements or evidence of such Confidential Information and any copies
thereof, in Consultant possession or under Consultant control at the request of BLSI or, in the
absence of such a request, upon the termination of this Agreement.
	 
	 	C.	 	All Developments shall be “works made for hire” and the exclusive property of BLSI.
Consultant shall promptly and fully disclose to BLSI all Developments. Consultant shall keep
and maintain complete records of all Developments and of all work carried out by Consultant
under the terms of this Agreement. These records shall also be “works made for hire” and the
exclusive property of BLSI. Consultant may keep one copy of these records in Consultant’s
files solely for reference purposes. Consultant assigns to BLSI all of Consultant’s right,
title and interest in and to any and all Developments. During and after the term of this
Agreement, Consultant will cooperate fully in obtaining patent and other proprietary
protection for any and all Developments, all in the name of BLSI and at BLSI’s cost and
expense, and, without limitation, shall execute and deliver all requested applications,
assignments and other documents, and take such other measures as BLSI shall reasonably
request, in order to perfect and enforce BLSI’s rights in any and all Developments.
Consultant hereby appoints BLSI his attorney-in-fact to execute and deliver any such documents
on behalf of Consultant in the event Consultant shall fail to do so. Consultant shall not use
any third party intellectual property or facilities in performing the consulting services
contemplated by this Agreement or engage in any other activities that would result in a third
party having an ownership interest in any Developments.
	 
	 	 	 	For purposes of this Agreement, “Development” means ideas, concepts, discoveries, inventions,
developments, improvements, know-how, trade secrets, methodologies, biological substances,
materials, devices, equipment, algorithms, notation systems, computer software and hardware,
data, documentation and reports (whether or not protectible under state, federal or foreign
patent, trademark, copyright or similar laws) that are developed or conceived or reduced to
practice by Consultant (i) during the term of this Agreement and (ii) (a) in performance of the
consulting services rendered under this Agreement, (b) by use of BLSI’s intellectual property,
equipment or facilities or (c) otherwise at BLSI’s expense.

 

 

	6.	 	Indemnification. Consultant agrees to indemnify BLSI and pay all BLSI damages and all
other costs associated with third party claims arising out of Consultant’s negligent
performance or actions under this Agreement.

	7.	 	Limited Non-competition. During the term of this Agreement and for a period of one
year thereafter, Consultant shall not provide consulting services to any business or entity
with respect to a project or product which competes with a project or product of BLSI and/or
for which Consultant provides or provided consulting services under this Agreement, including
any project that relates to diagnostic imaging agents for CNS disorders and drug programs for
neuroregenerative and neurodegenerative disorders.

	8.	 	No Prior Agreements. Consultant represents that his performance under this Agreement
does not and shall not breach any fiduciary or other duty or any covenant, agreement or
understanding (including, without limitation, any agreement relating to any obligation with
respect to proprietary information, non-solicitation, non-competition, or knowledge or data
acquired by Consultant in confidence, trust or otherwise prior to or during Consultant’s
engagement by BLSI) to which Consultant is a party or by the terms of which Consultant may be
bound. Consultant covenants and agrees that he shall not disclose to BLSI, or induce BLSI to
use, any such proprietary information, knowledge or data belonging to any previous or
concurrent employer or client or others.

	9.	 	BLSI and Government Regulations; No Debarment. In performing the consulting services
contemplated by this Agreement, Consultant agrees to comply with all business conduct,
regulatory and health and safety guidelines or regulations established by BLSI or any
governmental authority with respect to the business of the BLSI. Consultant represents,
warrants and agrees that he has not been, and during the term of this Agreement, will not be,
debarred by the Food and Drug Administration from working in or providing services to any
pharmaceutical or biotechnology company under the Federal Food, Drug and Cosmetic Act, or
under any other applicable law. Consultant agrees to immediately notify BLSI if Consultant
becomes aware of any such circumstances during the term of this Agreement.

	10.	 	Independent Contractor. Consultant shall at all times be an independent contractor
hereunder, and not a co-venturer, agent, employee or representative of BLSI, and no act,
action or omission to act of Consultant shall in any way be binding upon or obligate BLSI. No
change in Consultant’s duties as a consultant of BLSI shall result in, or be deemed to be, a
modification of the terms of this Agreement. Consultant shall not be treated as an employee
for Federal tax purposes. Consultant hereby represents and warrants to BLSI that he is an
independent contractor for Federal, state and local tax purposes. Further, Consultant hereby
covenants and agrees to pay any and all Federal, state and local taxes required by law to be
paid by an independent contractor, including, without limitation, any taxes imposed by the
Self Employment Contribution Act.

	11.	 	Governing Law and Venue. In view of the fact that the principal office of BLSI is
located in Massachusetts, the construction and interpretation of this Agreement shall at all
times and in all respects be governed by the substantive laws of Massachusetts,

 

 

	 	 	without regard to its rules regarding conflicts of law. Any legal action taken by either party shall take
place in the State of Massachusetts. In the event of any legal action or claim concerning the
terms of this Agreement or the performance of any party under the terms of this agreement, all
reasonable legal fees, costs and expenses of the prevailing party relating to such legal
action or claim shall promptly be paid by the other party.

	12.	 	Notices. Any notice required to be given hereunder shall be sufficient if in
writing, and received by courier service (with proof of service) or certified or registered
mail (return receipt requested, first-class postage prepaid), in the case of Consultant, to
Consultant address as shown on BLSI’s records, and, in the case of BLSI, to its principal
office.

	13.	 	General. This Agreement contains the entire agreement between the parties and
supersedes all proposals, representations, negotiations, agreements and other communications
between the parties, whether written or oral. No change or modification hereof shall be valid
or binding unless the same is in writing and signed by the party intended to be bound. This
Agreement shall be binding upon, and shall inure to the benefit of, BLSI and Consultant, and
their respective successors. However, Consultant may not assign this Agreement or any duties
hereunder without the express written authorization of BLSI. The provisions of this Agreement
shall be deemed severable, and the invalidity or unenforceability of any one or more of the
provisions hereof shall not affect the validity and enforceability of the other provisions
hereof. The headings and other captions in this Agreement are for convenience and reference
only and shall not be used in interpreting, construing or enforcing any of the provisions of
this Agreement. Neither party shall be liable for the failure to perform its obligations under
this Agreement due to events beyond such party’s reasonable control including, but not limited
to, strikes, riots, wars, fire, acts of God or acts in compliance with any applicable law,
regulation or order (whether valid or invalid) of any court or governmental body. No waiver of
any provision of this Agreement shall be valid unless the same is in writing and signed by the
party against whom such waiver is sought to be enforced; moreover, no valid waiver of any
provision of this Agreement at any time shall be deemed a waiver of any other provision of
this Agreement at such time or shall be deemed a valid waiver of such provision at any other
time.

	14.	 	Counterparts. This Agreement may be executed by fax and in two or more counterparts,
each of which when so executed and delivered shall be deemed to be an original and all of
which together shall be deemed to be one and the same agreement.

*****

 

 

IN WITNESS WHEREOF, BLSI and Robert S. Langer have duly executed this Agreement intending to be
bound thereby.

Signed for and on behalf of BOSTON LIFE SCIENCES, INC.:

	 	 	 	 	 	 	 	 	 
	Signature:

	 	/s/ Mark Pykett
	 	 
	 	Date: 9-29-06
	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	     Mark Pykett	 	 	 	 	 	 
	 

	 	     President & Chief Operating Officer	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Signed for and on behalf of Robert S. Langer	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Signature:

	 	/s/ Robert S. Langer
	 	 	 	Date: 9-27-06

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]